Toggle Sidebar
Home
AI Agent
Annotations
Watchlists
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
AMGN US
Amgen Inc
(AMGN US)
$439.26
-8.02
1.79%
Ext:
$440.44
+1.18
0.27%
(Market Closed · 23:47:20 UTC)
Follow
SEC Filings
Select Filings
Ask in Filing
Financials
(135)
Expand
10-Q
Q2
ended 30 Jun 2026
4 Aug
10-Q
Q1
ended 31 Mar 2026
30 Apr
10-K
FY 2025
ended 31 Dec 2025
13 Feb
10-Q
Q3
ended 30 Sept 2025
4 Nov 2025
10-Q
Q2
ended 30 Jun 2025
6 Aug 2025
10-Q
Q1
ended 31 Mar 2025
2 May 2025
10-K
FY 2024
ended 31 Dec 2024
14 Feb 2025
10-Q
Q3
ended 30 Sept 2024
31 Oct 2024
10-Q
Q2
ended 30 Jun 2024
7 Aug 2024
10-Q
Q1
ended 31 Mar 2024
3 May 2024
10-K
FY 2023
ended 31 Dec 2023
14 Feb 2024
10-Q
Q3
ended 30 Sept 2023
31 Oct 2023
10-Q
Q2
ended 30 Jun 2023
4 Aug 2023
10-Q
Q1
ended 31 Mar 2023
28 Apr 2023
10-K
FY 2022
ended 31 Dec 2022
9 Feb 2023
Events
(324)
Expand
8-K
EARNINGS RELEASE
4 Aug
8-K
<ITEMS>1.05
31 Jul
8-K
Submission of Matters to a Vote of Security Holders
20 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
19 May
8-K
EARNINGS RELEASE
30 Apr
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
22 Apr
8-K
Entry into a Material Definitive Agreement
19 Feb
8-K
EARNINGS RELEASE
3 Feb
8-K
Termination of a Material Definitive Agreement
30 Jan
8-K
EARNINGS RELEASE
4 Nov 2025
8-K
EARNINGS RELEASE
5 Aug 2025
8-K
Submission of Matters to Shareholder Vote
27 May 2025
8-K
EARNINGS RELEASE
1 May 2025
8-K
EARNINGS RELEASE
4 Feb 2025
8-K
AMGN-2024.9.30 EARNINGS RELEASE
30 Oct 2024
Insider Ownership
(2K)
Expand
3
Dittrich Thomas J.W.
4 Sep
4
Khosla Rachna
13 Aug
4
Busch Matthew C.
12 Aug
4
ISHRAK OMAR
10 Aug
4
HOLLEY CHARLES M
10 Aug
4
Drake Michael V
10 Aug
4
Miller Derek
7 Aug
4
Grygiel Nancy A.
7 Aug
4
MILES AMY E
21 May
4
Kullman Ellen Jamison
21 May
4
Klotman Mary E.
21 May
4
Jacks Tyler
21 May
4
ISHRAK OMAR
21 May
4
HOLLEY CHARLES M
21 May
4
Garland Greg C.
21 May
Beneficial Ownership
(123)
Expand
SC 13G
AMGEN INC
14 May
SC 13G
AMGEN INC
29 Apr
SC 13G/A
AMGEN INC
26 Mar
SC 13G/A
AMGEN INC
8 Sep 2025
SC 13G/A
AMGEN INC
17 Apr 2025
SC 13G/A
NewAmsterdam Pharma Co N.V.
23 Aug 2024
SC 13G/A
AMGEN INC
13 Feb 2024
SC 13G/A
AMGEN INC
30 Jan 2024
SC 13G/A
AMGEN INC
25 Jan 2024
SC 13D
Neumora Therapeutics, Inc.
27 Sep 2023
SC 13G/A
Jasper Therapeutics, Inc.
10 Feb 2023
SC 13G/A
AMGEN INC
9 Feb 2023
SC 13G/A
AMGEN INC
7 Feb 2023
SC 13G/A
AMGEN INC
6 Feb 2023
SC 13G
NewAmsterdam Pharma Co N.V.
2 Dec 2022
Other Ownership
(85)
Expand
144
Khosla Rachna
13 Aug
144
Khosla Rachna
11 Aug
144
Miller Derek
6 Aug
144/A
Grygiel Nancy A.
6 Aug
144
Grygiel Nancy A.
6 Aug
11-K
Annual report (employee stock purchase/savings/profit sharing plans)
11 Jun
11-K
Annual report (employee stock purchase/savings/profit sharing plans)
11 Jun
144
Grygiel Nancy A.
4 May
144
Santos Esteban
27 Feb
144
Busch Matthew C.
19 Feb
144
Grygiel Nancy A.
20 Nov 2025
144
Gordon Murdo
12 Nov 2025
144
Khosla Rachna
12 Nov 2025
144
Grygiel Nancy A.
20 Aug 2025
11-K
Annual report (employee stock purchase/savings/profit sharing plans)
12 Jun 2025
Proxies
(134)
Expand
DEFA14A
Definitive additional materials
21 Apr
DEFA14A
Definitive additional materials
15 Apr
DEFA14A
Definitive additional materials
7 Apr
DEF 14A
Definitive proxy statement
7 Apr
ARS
Annual report to security holders
31 Mar
DEFA14A
Definitive additional materials
29 Apr 2025
DEFA14A
Definitive additional materials
17 Apr 2025
PX14A6G
Notice of exempt solicitation
16 Apr 2025
DEF 14A
Definitive proxy statement
9 Apr 2025
DEFA14A
Definitive additional materials
9 Apr 2025
ARS
Annual report to security holders
2 Apr 2025
DEFA14A
Definitive additional materials
10 May 2024
DEFA14A
Definitive additional materials
3 May 2024
DEFA14A
Definitive additional materials
26 Apr 2024
DEFA14A
Definitive additional materials
17 Apr 2024
Registrations
(250)
Expand
25-NSE
Notification of removal from listing
24 Feb
424B2
Prospectus filing (Rule 424(b)(2))
18 Feb
FWP
Free writing prospectus
17 Feb
424B3
Prospectus filing (Rule 424(b)(3))
17 Feb
S-3ASR
Automatic shelf registration statement (S-3)
13 Feb
S-8
Registration statement (employee benefit plan)
12 Jun 2024
S-8
Registration statement (employee benefit plan)
6 Oct 2023
424B2
Prospectus filing (Rule 424(b)(2))
17 Feb 2023
FWP
Free writing prospectus
16 Feb 2023
424B3
Prospectus filing (Rule 424(b)(3))
14 Feb 2023
S-3ASR
Automatic shelf registration statement (S-3)
9 Feb 2023
424B2
Prospectus filing (Rule 424(b)(2))
16 Aug 2022
424B3
Prospectus filing (Rule 424(b)(3))
15 Aug 2022
FWP
Free writing prospectus
15 Aug 2022
424B2
Prospectus filing (Rule 424(b)(2))
18 Feb 2022
Filing Review Correspondence
(12)
Expand
CORRESP
Filing review correspondence
22 Apr 2024
CORRESP
Filing review correspondence
13 Apr 2021
CORRESP
Filing review correspondence
9 Feb 2021
CORRESP
Filing review correspondence
7 Dec 2016
UPLOAD
Filing review upload
10 Apr 2009
CORRESP
Filing review correspondence
1 Apr 2009
UPLOAD
Filing review upload
24 Mar 2009
UPLOAD
Filing review upload
30 Aug 2006
CORRESP
Filing review correspondence
27 Jul 2006
CORRESP
Filing review correspondence
9 Jun 2006
UPLOAD
Filing review upload
25 May 2006
UPLOAD
Filing review upload
6 Feb 2006
SEC Orders And Notices
(36)
Expand
EFFECT
Notice of effectiveness
15 Apr 2021
CT ORDER
Confidential treatment order
24 Oct 2019
CT ORDER
Confidential treatment order
3 Jun 2019
CT ORDER
Confidential treatment order
30 May 2018
CT ORDER
Confidential treatment order
17 May 2018
CT ORDER
Confidential treatment order
4 Dec 2017
CT ORDER
Confidential treatment order
8 Sep 2017
CT ORDER
Confidential treatment order
15 Aug 2017
CT ORDER
Confidential treatment order
26 May 2017
CT ORDER
Confidential treatment order
8 May 2017
CT ORDER
Confidential treatment order
6 Mar 2017
EFFECT
Notice of effectiveness
9 Dec 2016
CT ORDER
Confidential treatment order
23 Apr 2015
EFFECT
Notice of effectiveness
18 Dec 2014
EFFECT
Notice of effectiveness
18 Dec 2014
Tender Offers And Going Private
(77)
Expand
SC TO-T/A
Tender offer statement (third-party, amendment)
16 Apr 2021
SC TO-T/A
Tender offer statement (third-party, amendment)
8 Apr 2021
SC TO-T/A
Tender offer statement (third-party, amendment)
6 Apr 2021
SC TO-T/A
Tender offer statement (third-party, amendment)
22 Mar 2021
SC TO-T
Tender offer statement (third-party)
18 Mar 2021
SC TO-C
Tender offer statement (communication)
5 Mar 2021
SC TO-C
Tender offer statement (communication)
4 Mar 2021
SC TO-C
Tender offer statement (communication)
4 Mar 2021
SC TO-I/A
Tender offer statement (issuer, amendment)
8 Mar 2018
SC TO-I/A
Tender offer statement (issuer, amendment)
6 Mar 2018
SC TO-I/A
Tender offer statement (issuer, amendment)
26 Feb 2018
SC TO-I/A
Tender offer statement (issuer, amendment)
23 Feb 2018
SC TO-I/A
Tender offer statement (issuer, amendment)
20 Feb 2018
SC TO-I/A
Tender offer statement (issuer, amendment)
14 Feb 2018
SC TO-I/A
SCHEDULE TO-I/A (AMENDMENT NO. 1)
5 Feb 2018
Exempt Offerings
(5)
Expand
D/A
06b
23 Jan 2015
D/A
06b
29 Jan 2014
D/A
Notice of exempt offering of securities (Reg D, amendment)
4 Feb 2013
D/A
Notice of exempt offering of securities (Reg D, amendment)
29 Feb 2012
D
Notice of exempt offering of securities (Reg D)
14 Mar 2011
Other
(12)
Expand
25
25
28 Dec 2020
CERT
CERT
28 Dec 2020
NO ACT
AUTO-GENERATED PAPER DOCUMENT
10 Feb 2017
SD
SD
31 May 2016
CERTNYS
AUTO-GENERATED PAPER DOCUMENT
1 Mar 2016
NO ACT
AUTO-GENERATED PAPER DOCUMENT
25 Jan 2012
NO ACT
AUTO-GENERATED PAPER DOCUMENT
17 Feb 2011
NO ACT
AUTO-GENERATED PAPER DOCUMENT
3 Mar 2009
NO ACT
AUTO-GENERATED PAPER DOCUMENT
26 Jan 2005
NO ACT
AUTO-GENERATED PAPER DOCUMENT
10 Feb 2004
NO ACT
AUTO-GENERATED PAPER DOCUMENT
12 Jan 2004
10-K405
10-K405
7 Mar 2000
Financials & Metrics
Financials
Charting
Short Interest
Employees